Tularemia

BIODEFENSE: Research Methodology and Animal Models

Volumn , Issue , 2005, Pages 137-162

  Adamovicz, Jeffery J ^a   Wargo, Erica P ^a   Waag, David M ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85152349793     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420038118-13     Document Type: Chapter

References (124)

1. Ohara, S., Studies on yato-byo (Ohara’s disease, tularemia in Japan). I, Jpn J Exp Med 24(2), 69-79, 1954.
2. Wherry, W. B. and Lamb, B. H., Infection of man with Bacterium tularense. 1914, J Infect Dis 189(7), 1321-9, 2004.
3. Harris, S., Japanese biological warfare research on humans: a case study of microbiology and ethics, Ann N Y Acad Sci 666, 21-52, 1992.
4. Alibek, K., Biohazard, Random House, New York, 1999.
5. Christopher, G. W., et al., Biological warfare. A historical perspective, JAMA 278, 412-417, 1977.
6. Greub, G. and Raoult, D., Microorganisms resistant to free-living amoebae, Clin Microbiol Rev 17(2), 413-33, 2004.
7. Tarnvik, A., et al., Francisella tularensis - a model for studies of the immune response to intracellular bacteria in man, Immunology 76(3), 349-54, 1992.
8. Whipp, M. J., et al., Characterization of a novicida-like subspecies of Francisella tularensis isolated in Australia, J Med Microbiol 52 (Pt 9), 839-42, 2003.
9. Samrakandi, M. M., et al., Genome diversity among regional populations of Francisella tularensis subspecies tularensis and Francisella tularensis subspecies holarctica isolated from the US, FEMS Microbiol Lett 237(1), 9-17, 2004.
10. Johansson, A., et al., Worldwide genetic relationships among Francisella tularensis isolates determined by multiple-locus variable-number tandem repeat analysis, J Bacteriol 186(17), 5808-18, 2004.
11. Bernard, K., et al., Early recognition of atypical Francisella tularensis strains lacking a cysteine requirement, J Clin Microbiol 32(2), 551-3, 1994.
12. Reintjes, R., et al., Tularemia outbreak investigation in Kosovo: case control and environmental studies, Emerg Infect Dis 8(1), 69-73, 2002.
13. Hood, A. M., Virulence factors of Francisella tularensis, J Hyg (Lond) 79(1), 47-60, 1977.
14. Sandstrom, G., Lofgren, S., and Tarnvik, A., A capsule-deficient mutant of Francisella tularensis LVS exhibits enhanced sensitivity to killing by serum but diminished sensitivity to killing by polymorphonuclear leukocytes, Infect Immun 56(5), 1194-202, 1988.
15. Gil, H., Benach, J. L., and Thanassi, D. G., Presence of pili on the surface of Francisella tularensis, Infect Immun 72(5), 3042-7, 2004.
16. Hubalek, M., et al., Comparative proteome analysis of cellular proteins extracted from highly virulent Francisella tularensis ssp. tularensis and less virulent F. tularensis ssp. holarctica and F. tularensis ssp. mediaasiatica, Proteomics 4(10), 3048-60, 2004.
17. Sandstrom, G., et al., Immunogenicity and toxicity of lipopolysaccharide from Francisella tularensis LVS, FEMS Microbiol Immunol 5(4), 201-10, 1992.
18. Ancuta, P., et al., Inability of the Francisella tularensis lipopolysaccharide to mimic or to antagonize the induction of cell activation by endotoxins, Infect Immun 64(6), 2041-6, 1996.
19. Chen, W., et al., Toll-like receptor 4 (TLR4) does not confer a resistance advantage on mice against low-dose aerosol infection with virulent type A Francisella tularensis, Microb Pathog 37(4), 185-91, 2004.
20. Chen, W., et al., Susceptibility of immunodeficient mice to aerosol and systemic infection with virulent strains of Francisella tularensis, Microb Pathog 36(6), 311-8, 2004.
21. Dreisbach, V. C., Cowley, S., and Elkins, K. L., Purified lipopolysaccharide from Francisella tularensis live vaccine strain (LVS) induces protective immunity against LVS infection that requires B cells and gamma interferon, Infect Immun 68(4), 1988-96, 2000.
22. Conlan, J. W., et al., Mice vaccinated with the O-antigen of Francisella tularensis LVS lipopolysaccharide conjugated to bovine serum albumin develop varying degrees of protective immunity against systemic or aerosol challenge with virulent type A and type B strains of the pathogen, Vaccine 20 (29-30), 3465-71, 2002.
23. Kieffer, T. L., et al., Francisella novicida LPS has greater immunobiological activity in mice than F. tularensis LPS, and contributes to F. novicida murine pathogenesis, Microbes Infect 5(5), 397-403, 2003.
24. Lindgren, H., et al., Factors affecting the escape of Francisella tularensis from the phagolysosome, J Med Microbiol 53 (Pt 10), 953-8, 2004.
25. Telepnev, M., et al., Francisella tularensis inhibits Toll-like receptor-mediated activation of intracellular signalling and secretion of TNF-alpha and IL-1 from murine macrophages, Cell Microbiol 5(1), 41-51, 2003.
26. Tarnvik, A., Nature of protective immunity to Francisella tularensis, Rev Infect Dis 11(3), 440-51, 1989.
27. Golovliov, I., et al., An attenuated strain of the facultative intracellular bacterium Francisella tularensis can escape the phagosome of monocytic cells, Infect Immun 71(10), 5940-50, 2003.
28. Clemens, D. L., Lee, B. Y., and Horwitz, M. A., Virulent and avirulent strains of Francisella tularensis prevent acidification and maturation of their phagosomes and escape into the cytoplasm in human macrophages, Infect Immun 72(6), 3204-17, 2004.
29. Nano, F. E., et al., A Francisella tularensis pathogenicity island required for intramacrophage growth, J Bacteriol 186(19), 6430-6, 2004.
30. Larsson, P., et al., The complete genome sequence of Francisella tularensis, the causative agent of tularemia, Nat Genet 37(2), 153-9, 2005.
31. Karlsson, J., et al., Sequencing of the Francisella tularensis strain Schu 4 genome reveals the shikimate and purine metabolic pathways, targets for the construction of a rationally attenuated auxotrophic vaccine, Microb Comp Genomics 5(1), 25-39, 2000.
32. Lauriano, C. M., et al., Allelic exchange in Francisella tularensis using PCR products, FEMS Microbiol Lett 229(2), 195-202, 2003.
33. Kawula, T. H., et al., Use of transposon-transposase complexes to create stable insertion mutant strains of Francisella tularensis LVS, Appl Environ Microbiol 70(11), 6901-4, 2004.
34. Gilmore, R. D., Jr., et al., Identification of Francisella tularensis genes encoding exported membrane-associated proteins using TnphoA mutagenesis of a genomic library, Microb Pathog 37(4), 205-13, 2004.
35. Maier, T. M., et al., Construction and characterization of a highly efficient Francisella shuttle plasmid, Appl Environ Microbiol 70(12), 7511-9, 2004.
36. Tigertt, W. D., Soviet viable Pasteurella tularensis vaccines. A review of selected articles, Bacteriol Rev 26, 354-73, 1962.
37. Eigelsbach, H. T. and Downs, C. M., Prophylactic effectiveness of live and killed tularemia vaccines. I. Production of vaccine and evaluation in the white mouse and guinea pig, J Immunol 87, 415-25, 1961.
38. Waag, D. M., et al., Immunogenicity of a new lot of Francisella tularensis live vaccine strain in human volunteers, FEMS Immunol Med Microbiol 13(3), 205-9, 1996.
39. Waag, D. M., et al., Cell-mediated and humoral immune responses induced by scarification vaccination of human volunteers with a new lot of the live vaccine strain of Francisella tularensis, J Clin Microbiol 30(9), 2256-64, 1992.
40. Waag, D. M., et al., Cell-mediated and humoral immune responses after vaccination of human volunteers with the live vaccine strain of Francisella tularensis, Clin Diagn Lab Immunol 2(2), 143-8, 1995.
41. Saslaw, S., et al., Tularemia vaccine study. II. Respiratory challenge, Arch Intern Med 107, 702-14, 1961.
42. Saslaw, S., et al., Tularemia vaccine study. I. Intracutaneous challenge, Arch Intern Med 107, 689-701, 1961.
43. Elkins, K. L., Cowley, S. C., and Bosio, C. M., Innate and adaptive immune responses to an intracellular bacterium, Francisella tularensis live vaccine strain, Microbes Infect 5(2), 135-42, 2003.
44. Cherwonogrodzky, J. W., Knodel, M. H., and Spence, M. R., Increased encapsulation and virulence of Francisella tularensis live vaccine strain (LVS) by subculturing on synthetic medium, Vaccine 12(9), 773-5, 1994.
45. Meka-Mechenko, T., et al., Clinical and epidemiological characteristic of tularemia in Kazakhstan, Przegl Epidemiol 57(4), 587-91, 2003.
46. Tularemia - Oklahoma, 2000, MMWR Morb Mortal Wkly Rep 50(33), 704-6, 2001.
47. Bell, J. F. and Stewart, S. J., Chronic shedding tularemia nephritis in rodents: possible relation to occurrence of Francisella tularensis in lotic waters, J Wildl Dis 11(3), 421-30, 1975.
48. Young, L. S., et al., Tularemia epidemic: Vermont, 1968. Forty-seven cases linked to contact with muskrats, N Engl J Med 280(23), 1253-60, 1969.
49. Morner, T., The ecology of tularaemia, Rev Sci Tech 11(4), 1123-30, 1992.
50. Berdal, B. P., et al., Field detection of Francisella tularensis, Scand J Infect Dis 32(3), 287-91, 2000.
51. Greco, D. and Ninu, E., A family outbreak of tularemia, Eur J Epidemiol 1(3), 232-3, 1985.
52. Hoel, T., et al., Water-and airborne Francisella tularensis biovar palaearctica isolated from human blood, Infection 19(5), 348-50, 1991.
53. Feldman, K. A., et al., Tularemia on Martha’s Vineyard: seroprevalence and occupational risk, Emerg Infect Dis 9(3), 350-4, 2003.
54. McCrumb, F. R., Aerosol infection of man with Pasteurella tularensis, Bacteriol Rev 25, 262-267, 1961.
55. Evans, M. E., et al., Tularemia: a 30-year experience with 88 cases, Medicine (Baltimore) 64(4), 251-69, 1985.
56. Dennis, D. T., et al., Tularemia as a biological weapon: medical and public health management, JAMA 285(21), 2763-73, 2001.
57. Samoilova, L. V., et al., [Experimental study of the pulmonary form of plague, tularemia and pseudotuberculosis], Zh Mikrobiol Epidemiol Immunobiol (3), 110-4, 1977.
58. Stuart, B. M. and Pullen, R. L., Tularemia meningitis: review of the literature and report of a case with post-mortem observations, Arch Intern Med 76, 163-166, 1945.
59. Eigelsbach, H. T., et al., Tularemia: the monkey as a model for man. Use of nonhuman primates in drug evaluation, a symposium., in Use of nonhuman primates in drug evaluation, a symposium, Vagtborg, H., Ed., 1968, pp. 230-48.
60. Anda, P., et al., Waterborne outbreak of tularemia associated with crayfish fishing, Emerg Infect Dis 7 (3 Suppl), 575-82, 2001.
61. Bevanger, L., Maeland, J. A., and Naess, A. I., Agglutinins and antibodies to Francisella tularensis outer membrane antigens in the early diagnosis of disease during an outbreak of tularemia, J Clin Microbiol 26(3), 433-7, 1988.
62. Gurcan, S., et al., An outbreak of tularemia in Western Black Sea region of Turkey, Yonsei Med J 45(1), 17-22, 2004.
63. Quan, S. F., Quantitative oral infectivity of tularemia for laboratory animals, Am J Hyg 59(3), 282-90, 1954.
64. Helvaci, S., et al., Tularemia in Bursa, Turkey: 205 cases in ten years, Eur J Epidemiol 16(3), 271-6, 2000.
65. Francis, E., A summary of present knowledge of tularaemia, Medicine 7, 411-432, 1928.
66. Quan, S. F., McManus, A. G., and Von Fintel, H., Infectivity of tularemia applied to intact skin and ingested in drinking water, Science 123(3204), 942-3, 1956.
67. Syrjala, H., et al., Bronchial changes in airborne tularemia, J Laryngol Otol 100(10), 1169-76, 1986.
68. Pullen, R. L. and Stuart, B. M., Tularemia: analysis of 225 cases, JAMA 129, 495-500, 1945.
69. Conlan, J. W., et al., Experimental tularemia in mice challenged by aerosol or intradermally with virulent strains of Francisella tularensis: bacteriologic and histopathologic studies, Microb Pathog 34(5), 239-48, 2003.
70. Stuart, B. M. and Pullen, R. L., Tularemic pneumonia: review of American literature and report of 15 additional cases, Am J Med Sci 210, 223-236, 1945.
71. Koskela, P. and Salminen, A., Humoral immunity against Francisella tularensis after natural infection, J Clin Microbiol 22(6), 973-9, 1985.
72. Enderlin, G., et al., Streptomycin and alternative agents for the treatment of tularemia: review of the literature, Clin Infect Dis 19(1), 42-7, 1994.
73. Russell, P., et al., The efficacy of ciprofloxacin and doxycycline against experimental tularaemia, J Antimicrob Chemother 41(4), 461-5, 1998.
74. Conley, J., et al.., Aerosol delivery of liposome-encapsulated ciprofloxacin: aerosol characterization and efficacy against Francisella tularensis infection in mice, Antimicrob Agents Chemother 41(6), 1288-92, 1997.
75. Avashia, S. B., et al., First reported prairie dog-to-human tularemia transmission, Texas, 2002, Emerg Infect Dis 10(3), 483-6, 2004.
76. Petersen, J. M., et al., Laboratory analysis of tularemia in wild-trapped, commercially traded prairie dogs, Texas, 2002, Emerg Infect Dis 10(3), 419-25, 2004.
77. Bell, J. F. and Stewart, S. J., Quantum differences in oral susceptibility of voles, Microtus pennsylvanicus, to virulent Francisella tularensis type B, in drinking water: implications to epidemiology, Ecol Dis 2(2), 151-5, 1983.
78. Bigler, W. J., et al., Wildlife and environmental health: raccoons as indicators of zoonoses and pollutants in southeastern United States, J Am Vet Med Assoc 167(7), 592-7, 1975.
79. Evans, M. E., et al., Tularemia and the tomcat, JAMA 246 (12), 1343, 1981.
80. Shoemaker, D., et al., Humoral immune response of cottontail rabbits naturally infected with Francisella tularensis in southern Illinois, J Wildl Dis 33(4), 733-7, 1997.
81. Woods, J. P., et al., Tularemia in two cats, J Am Vet Med Assoc 212(1), 81-3, 1998.
82. Morner, T. and Mattsson, R., Experimental infection of five species of raptors and of hooded crows with Francisella tularensis biovar palaearctica, J Wildl Dis 24(1), 15-21, 1988.
83. Bivin, W. S. and Hogge, A. L., Jr., Quantitation of susceptibility of swine to infection with Pasteurella tularensis, Am J Vet Res 28(126), 1619-21, 1967.
84. Fortier, A. H., et al., Live vaccine strain of Francisella tularensis: infection and immunity in mice, Infect Immun 59(9), 2922-8, 1991.
85. Conlan, J. W., et al., Different host defences are required to protect mice from primary systemic vs pulmonary infection with the facultative intracellular bacterial pathogen, Francisella tularensis LVS, Microb Pathog 32(3), 127-34, 2002.
86. Eigelsbach, H. T., et al., Murine model for study of cell-mediated immunity: protection against death from fully virulent Francisella tularensis infection, Infect Immun 12(5), 999-1005, 1975.
87. Anthony, L. S., Skamene, E., and Kongshavn, P. A., Influence of genetic background on host resistance to experimental murine tularemia, Infect Immun 56(8), 2089-93, 1988.
88. Chen, W., et al., Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host genetic background, Vaccine 21 (25-26), 3690-700, 2003.
89. Shen, H., Chen, W., and Conlan, J. W., Susceptibility of various mouse strains to systemically-or aerosol-initiated tularemia by virulent type A Francisella tularensis before and after immunization with the attenuated live vaccine strain of the pathogen, Vaccine 22 (17-18), 2116-21, 2004.
90. Downs, C. M. and Woodward, J. M., Studies on pathogenesis and immunity in tularemia; immunogenic properties for the white mouse of various strains of Bacterium tularense, J Immunol 63(2), 147-63, 1949.
91. Anthony, L. S. and Kongshavn, P. A., Experimental murine tularemia caused by Francisella tularensis, live vaccine strain: a model of acquired cellular resistance, Microb Pathog 2(1), 3-14, 1987.
92. Shen, H., Chen, W., and Conlan, J. W., Mice sublethally infected with Francisella novicida U112 develop only marginal protective immunity against systemic or aerosol challenge with virulent type A or B strains of F. tularensis, Microb Pathog 37(2), 107-10, 2004.
93. Conlan, J. W., Sjostedt, A., and North, R. J., CD4+ and CD8+ T-cell-dependent and -independent host defense mechanisms can operate to control and resolve primary and secondary Francisella tularensis LVS infection in mice, Infect Immun 62(12), 5603-7, 1994.
94. Polsinelli, T., Meltzer, M. S., and Fortier, A. H., Nitric oxide-independent killing of Francisella tularensis by IFN-gamma-stimulated murine alveolar macrophages, J Immunol 153(3), 1238-45, 1994.
95. Sumida, T., et al., Predominant expansion of V gamma 9/V delta 2 T cells in a tularemia patient, Infect Immun 60(6), 2554-8, 1992.
96. Sjostedt, A., Conlan, J. W., and North, R. J., Neutrophils are critical for host defense against primary infection with the facultative intracellular bacterium Francisella tularensis in mice and participate in defense against reinfection, Infect Immun 62(7), 2779-83, 1994.
97. Elkins, K. L., et al., Bacterial DNA containing CpG motifs stimulates lymphocytedependent protection of mice against lethal infection with intracellular bacteria, J Immunol 162(4), 2291-8, 1999.
98. Stenmark, S., et al., Specific antibodies contribute to the host protection against strains of Francisella tularensis subspecies holarctica, Microb Pathog 35(2), 73-80, 2003.
99. Cowley, S. C., Myltseva, S. V., and Nano, F. E., Phase variation in Francisella tularensis affecting intracellular growth, lipopolysaccharide antigenicity and nitric oxide production, Mol Microbiol 20(4), 867-74, 1996.
100. Olsuf’Ev, N. G. and Dunayeva, T. N., Study of the pathogenesis of experimental tularemia, J Hyg Epidemiol Microbiol Immunol 5, 409-422, 1961.
101. Jemski, J. V., Respiratory tularemia: comparison of selected routes of vaccination in Fischer 344 rats, Infect Immun 34(3), 766-72, 1981.
102. Savel’eva, R. A. and Gindin, A. P., [Concerning the pathogenesis of tularemia infection in the nonimmune and immune organism], Zh Mikrobiol Epidemiol Immunobiol 42(8), 43-50, 1965.
103. Olsufjev, N. G., Shlygina, K. N., and Ananova, E. V., Persistence of Francisella tularensis McCoy et Chapin tularemia agent in the organism of highly sensitive rodents after oral infection, J Hyg Epidemiol Microbiol Immunol 28(4), 441-54, 1984.
104. Morner, T., et al., Infections with Francisella tularensis biovar palaearctica in hares (Lepus timidus, Lepus europaeus) from Sweden, J Wildl Dis 24(3), 422-33, 1988.
105. Morner, T. and Sandstedt, K., A serological survey of antibodies against Francisella tularensis in some Swedish mammals, Nord Vet Med 35(2), 82-5, 1983.
106. Morner, T., Sandstrom, G., and Mattsson, R., Comparison of serum and lung extracts for surveys of wild animals for antibodies to Francisella tularensis biovar palaearctica, J Wildl Dis 24(1), 10-4, 1988.
107. Morner, T., et al., Surveillance and monitoring of wildlife diseases, Rev Sci Tech 21, 67-76, 2002.
108. Nutter, J. E. and Myrvik, Q. N., In vitro interactions between rabbit alveolar macrophages and Pasteurella tularensis, J Bacteriol 92, 645-651, 1966.
109. Aronova, N. V. and Pavlovich, N. V., [Comparative analysis of the immune response of a rabbit to antigens to live and killed Francisella species bacteria], Mol Gen Mikrobiol Virusol (2), 26-30, 2001.
110. Pavlovich, N. V., et al., [Species-and genus-specific antigenic epitopes of Francisella tularensis lipopolysaccharides], Mol Gen Mikrobiol Virusol (3), 7-12, 2000.
111. Schricker, R. L., et al., Pathogenesis of tularemia in monkeys aerogenically exposed to Francisella tularensis 425, Infect Immun 5(5), 734-44, 1972.
112. Hornick, R. B. and Eigelsbach, H. T., Tularemia epidemic - Vermont, 1968, N Engl J Med 281 (23), 1310, 1969.
113. Bell, J. F., Owen, C. R., and Larson, C. L., Virulence of Bacterium tularense. I. A study of the virulence of Bacterium tularense in mice, guinea pigs, and rabbits, J Infect Dis 97(2), 162-6, 1955.
114. Schricker, R. L., Pathogenesis of acute tularemia in the rabbit, Tech Manuscript 178, 1-13, 1964.
115. Baskerville, A. and Hambleton, P., Pathogenesis and pathology of respiratory tularaemia in the rabbit, Br J Exp Pathol 57(3), 339-47, 1976.
116. Eigelsbach, H. T. and Hornick, R. B., Characteristics of two major types of tularemia in North America: Influence of etiologic agent on severity of illness, in Twentieth Annual Southwestern Conference on Diseases in Nature Transmissable to Man, 1970.
117. Tulis, J. J., Eigelsbach, H. T., and Kerpsack, R. W., Host-parasite relationship in monkeys administered live tularemia vaccine, Am J Pathol 58(2), 329-36, 1970.
118. Hall, W. C., Kovatch, R. M., and Schricker, R. L., Tularaemic pneumonia: pathogenesis of the aerosol-induced disease in monkeys, J Pathol 110(3), 193-201, 1973.
119. Day, W. C. and Berendt, R. F., Experimental tularemia in Macaca mulatta: relationship of aerosol particle size to the infectivity of airborne Pasteurella tularensis, Infect Immun 5(1), 77-82, 1972.
120. Hambleton, P., et al., Changes in whole blood and serum components during Francisella tularensis and rabbit pox infections of rabbits, Br J Exp Pathol 58(6), 644-52, 1977.
121. Baskerville, A., Hambleton, P., and Dowsett, A. B., The pathology of untreated and antibiotic-treated experimental tularaemia in monkeys, Br J Exp Pathol 59(6), 615-23, 1978.
122. Baldwin, C. J., et al., Acute tularemia in three domestic cats, J Am Vet Med Assoc 199(11), 1602-5, 1991.
123. Elkins, K. L., et al., Introduction of Francisella tularensis at skin sites induces resistance to infection and generation of protective immunity, Microb Pathog 13(5), 417-21, 1992.
124. Olsufiev, N. G., Emelyanova, O. S., and Dunayeva, T. N., Comparative study of strains of B. tularense in the old and new world and their taxonomy, J Hyg Epidemiol Microbiol Immunol 3, 138-49, 1959.